Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evofem Biosciences Q2 EPS $(0.02), Sales $4.825M Up From $4.160M YoY

Author: Benzinga Newsdesk | August 14, 2025 07:49am
Evofem Biosciences (OTC:EVFM) reported quarterly losses of $(0.02) per share. The company reported $4.825 million in sales this quarter. This is a 15.99 percent increase over sales of $4.160 million the same period last year.

Posted In: EVFM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist